These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 16860418

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunoadsorption as treatment option in dilated cardiomyopathy.
    Felix SB, Staudt A.
    Autoimmunity; 2008 Sep; 41(6):484-9. PubMed ID: 18781476
    [Abstract] [Full Text] [Related]

  • 3. Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
    Caforio AL, Tona F, Bottaro S, Vinci A, Dequal G, Daliento L, Thiene G, Iliceto S.
    Autoimmunity; 2008 Feb; 41(1):35-45. PubMed ID: 18176863
    [Abstract] [Full Text] [Related]

  • 4. Immunoadsorption in dilated cardiomyopathy.
    Staudt A, Felix SB.
    Transfus Apher Sci; 2007 Oct; 37(2):187-90. PubMed ID: 18036989
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
    Horn S, Lueking A, Murphy D, Staudt A, Gutjahr C, Schulte K, König A, Landsberger M, Lehrach H, Felix SB, Cahill DJ.
    Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
    [Abstract] [Full Text] [Related]

  • 9. Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies.
    Trimpert C, Herda LR, Eckerle LG, Pohle S, Müller C, Landsberger M, Felix SB, Staudt A.
    Eur J Clin Invest; 2010 Aug; 40(8):685-91. PubMed ID: 20546018
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The pathogenesis of dilated cardiomyopathy: current progress].
    Mestroni L, Giacca M, Severini GM, Camerini F.
    G Ital Cardiol; 1992 Jan; 22(1):53-62. PubMed ID: 1624069
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Long-term benefits of immunoadsorption in β(1)-adrenoceptor autoantibody-positive transplant candidates with dilated cardiomyopathy.
    Dandel M, Wallukat G, Englert A, Lehmkuhl HB, Knosalla C, Hetzer R.
    Eur J Heart Fail; 2012 Dec; 14(12):1374-88. PubMed ID: 22892122
    [Abstract] [Full Text] [Related]

  • 18. Fc(gamma) receptors IIa on cardiomyocytes and their potential functional relevance in dilated cardiomyopathy.
    Staudt A, Eichler P, Trimpert C, Felix SB, Greinacher A.
    J Am Coll Cardiol; 2007 Apr 24; 49(16):1684-92. PubMed ID: 17448369
    [Abstract] [Full Text] [Related]

  • 19. Subclass specificity of autoantibodies against myosin in patients with idiopathic dilated cardiomyopathy: pro-inflammatory antibodies in DCM patients.
    Warraich RS, Dunn MJ, Yacoub MH.
    Biochem Biophys Res Commun; 1999 Jun 07; 259(2):255-61. PubMed ID: 10362496
    [Abstract] [Full Text] [Related]

  • 20. Immunoadsorption in patients with dilated cardiomyopathy.
    Herda LR, Felix SB, Staudt A.
    Atheroscler Suppl; 2009 Dec 29; 10(5):126-8. PubMed ID: 20129390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.